These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 16966724)

  • 21. Can personalized drugs pay off?
    Stipp D
    Fortune; 2002 May; 145(10):168. PubMed ID: 12025349
    [No Abstract]   [Full Text] [Related]  

  • 22. Improving the power of diagnostics in the era of targeted therapy and personalized healthcare.
    Walk EE
    Curr Opin Drug Discov Devel; 2010 Mar; 13(2):226-34. PubMed ID: 20205056
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacogenomic biomarker information in drug labels approved by the United States food and drug administration: prevalence of related drug use.
    Frueh FW; Amur S; Mummaneni P; Epstein RS; Aubert RE; DeLuca TM; Verbrugge RR; Burckart GJ; Lesko LJ
    Pharmacotherapy; 2008 Aug; 28(8):992-8. PubMed ID: 18657016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Finding a liability-free space in which personalized medicine can bloom.
    Evans BJ
    Clin Pharmacol Ther; 2007 Oct; 82(4):461-5. PubMed ID: 17713468
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacogenetics in Europe: barriers and opportunities.
    Gurwitz D; Zika E; Hopkins MM; Gaisser S; Ibarreta D
    Public Health Genomics; 2009; 12(3):134-41. PubMed ID: 19204415
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evolution of biomarkers: drug discovery to personalized medicine.
    Mukhtar M
    Drug Discov Today; 2005 Sep; 10(18):1216-8. PubMed ID: 16213413
    [No Abstract]   [Full Text] [Related]  

  • 27. Implications of pharmacogenomics for drug development.
    Kirk RJ; Hung JL; Horner SR; Perez JT
    Exp Biol Med (Maywood); 2008 Dec; 233(12):1484-97. PubMed ID: 18849536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The promise of personalized medicine: a conversation with Michael Svinte. Interview by Michael Millenson.
    Svinte M
    Health Aff (Millwood); 2006; 25(2):w54-60. PubMed ID: 16478734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patient-tailored medicine, Part one: the impact of race and genetics on medicine.
    Braff JP; Chatterjee B; Hochman M; Kelton T; Kennington J; Kolavala C; Layman K; Parver C; Selby MC; Washlick JR; Wolf R
    J Health Life Sci Law; 2008 Oct; 2(1):1-3, 5-36. PubMed ID: 19004296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genomic sciences and the medicine of tomorrow.
    Drews J
    Nat Biotechnol; 1996 Nov; 14(11):1516-8. PubMed ID: 9634812
    [No Abstract]   [Full Text] [Related]  

  • 31. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Promises of biomarkers in drug development--a reality check.
    Marrer E; Dieterle F
    Chem Biol Drug Des; 2007 Jun; 69(6):381-94. PubMed ID: 17581232
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toward theragnostics.
    Pene F; Courtine E; Cariou A; Mira JP
    Crit Care Med; 2009 Jan; 37(1 Suppl):S50-8. PubMed ID: 19104225
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The genomics and Personalized Medicine Act of 2006.
    Obama B
    Clin Adv Hematol Oncol; 2007 Jan; 5(1):39-40. PubMed ID: 17339825
    [No Abstract]   [Full Text] [Related]  

  • 35. Biomarker as a classifier in pharmacogenomics clinical trials: a tribute to 30th anniversary of PSI.
    Wang SJ
    Pharm Stat; 2007; 6(4):283-96. PubMed ID: 17957727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Current status and problems of tailor-made medicine in anticancer therapy].
    Miya T
    Gan To Kagaku Ryoho; 2007 Apr; 34(4):515-9. PubMed ID: 17431334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug development for orphan diseases in the context of personalized medicine.
    Brewer GJ
    Transl Res; 2009 Dec; 154(6):314-22. PubMed ID: 19931198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cancer biomarkers: current issues and future directions.
    Jain KK
    Curr Opin Mol Ther; 2007 Dec; 9(6):563-71. PubMed ID: 18041667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current overview of pharmacogenetics.
    McLeod HL
    Clin Adv Hematol Oncol; 2004 Apr; 2(4):205-7. PubMed ID: 16163181
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacogenetics: from description to prediction.
    Weber WW
    Clin Lab Med; 2008 Dec; 28(4):499-511. PubMed ID: 19059058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.